共 50 条
- [2] Surgical Safety of Deferred Cytoreductive Nephrectomy Following Pretreatment with Immune Checkpoint Inhibitor-based Dual Combination Therapy EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (03): : 373 - 374
- [4] A Swinging Pendulum: Bringing Back Cytoreductive Nephrectomy in the Era of Immune Checkpoint Inhibition EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (05): : 585 - 586
- [6] THE ROLE OF CYTOREDUCTIVE NEPHRECTOMY WITH IMMUNE CHECKPOINT INHIBITOR THERAPIES IN METASTATIC RENAL CELL CARCINOMA MURINE MODEL JOURNAL OF UROLOGY, 2023, 209 : E496 - E497
- [8] Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evidence of Disease? EUROPEAN UROLOGY OPEN SCIENCE, 2023, 55 : 15 - 22
- [9] Cytoreductive nephrectomy in the era of immune checkpoint inhibitors: a US Food and Drug Administration pooled analysis JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 116 (07): : 1043 - 1050
- [10] The role of plastic surgery in the immune checkpoint inhibitor era JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2022, 75 (02): : 915 - 916